Recent Updates
Recently added Catalysts
IMRN Positive Sentiment Score: 75/100

Immuron Presentation Australian Biologics Festival 2024

Wednesday, February 21, 2024 1 min read
Key Takeaway: Immuron Limited (ASX: IMC; NASDAQ: IMRN) announced that their Research & Development Manager, Joanne Casey, PhD, will present at the Australian Biologics Festival 2024 in Melbourne, Australia. This event highlights the company's commitment to sharing advancements in biopharmaceuticals. The presentation slide deck will be available on their website. Immuron focuses on developing orally delivered targeted polyclonal antibodies for infectious diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Immuron is presenting at a notable event, the Australian Biologics Festival 2024.
  • The presentation indicates active engagement in R&D and public visibility.
  • The company is focused on innovative treatments with targeted polyclonal antibodies.

Full Press Release Details

MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia.
A copy of the presentation slide deck is available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
Authorised for release by the Board of Immuron Limited.
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
For more information visit: http://www.immuron.com

Tags

Frequently Asked Questions

Who is presenting at the Australian Biologics Festival 2024?

Joanne Casey, PhD, the Research & Development Manager at Immuron Limited.

When is the Australian Biologics Festival 2024 taking place?

The festival is scheduled for Wednesday, 21st February 2024.

Where can I find the presentation slide deck?

The presentation slide deck is available on Immuron's website.

What does Immuron Limited focus on?

Immuron Limited focuses on developing orally delivered targeted polyclonal antibodies.

What type of diseases does Immuron target?

Immuron targets infectious diseases through its biopharmaceutical products.

Tags: IMRN Viatris Investor Conferences Healthcare Immuron Australian Biologics Festival biopharmaceuticals polyclonal antibodies infectious diseases
Last updated: Feb 21, 2024